Introduction
============

Sclerosing hemangioma (SH) of the lung is an uncommon tumor that was first described by Leibow and Hubbell in 1956 ([@b1-ol-07-04-0997]). SH is a lung tumor with a distinctive constellation of histological findings, including solid, papillary, sclerotic and hemorrhagic patterns ([@b2-ol-07-04-0997]). SH usually presents as a slow-growing benign mass in the lower lobes of middle-aged females ([@b3-ol-07-04-0997]). Several reports have described multicentric SHs or SHs with lymph node metastasis ([@b4-ol-07-04-0997]--[@b19-ol-07-04-0997]). Thus, SH is not always benign and it has the potential to metastasize.

Case report
===========

Clinical summary
----------------

A 40-year-old female was referred to Toyooka Hospital (Toyooka, Hyogo, Japan) after chest X-ray screening revealed a nodule in the left lower pulmonary field. The patient had no history of smoking. Family history was negative for relevant diseases. Blood tests revealed no increase in concentrations of tumor markers.

Chest computed tomography (CT) scanning revealed a nodule \~10 mm in diameter in the left lower lung ([Fig. 1](#f1-ol-07-04-0997){ref-type="fig"}), but no mediastinal or hilar lymph node swelling. The patient underwent lobectomy of the left lower lung with lymph node dissection.

Pathological findings
---------------------

Macroscopically, the tumor was sharply demarcated from the surrounding lung tissue and \~10×10×10 mm in size ([Fig. 2A](#f2-ol-07-04-0997){ref-type="fig"}). The cut surface was whitish and sclerotic.

Microscopically, the tumor demonstrated various features characteristic of SH, including angiomatoid areas, sclerosis, papillary structures lined with cuboidal cells and sheets of round to polygonal cells with slightly eosinophilic cytoplasms.

Immunohistochemically, the surface-lining cells were positive for napsin A, cytokeratin AE1/AE3 ([Fig. 3](#f3-ol-07-04-0997){ref-type="fig"}) and cytokeratin 7 (data not shown). The other cells were negative for these markers. However, all the tumor cells (both the surface-lining and polygonal cells) were positive for thyroid transcription factor 1 (TTF-1), which is expressed not only in thyroid epithelial cells but also in type II pneumocytes and Clara cells, and epithelial membrane antigen. These findings suggested that the tumor was an SH.

A small metastatic focus of SH was identified in one mediastinal lymph node. This lesion shared the papillary pattern of the primary tumor and was TTF-1-positive ([Fig. 4](#f4-ol-07-04-0997){ref-type="fig"}). The patient provided written informed consent. This study was approved by the Ethics Committee of Toyooka Hospital (Toyooka, Japan).

After two years of follow-up the patient has not exhibited any recurrence nor metastasis of the tumor.

Discussion
==========

Pulmonary SH was originally thought to be derived from the endothelium due to histological similarity to cutaneous SH ([@b1-ol-07-04-0997]).

In the present literature review, PubMed and JDream III (<http://jdream3.com/>) were used to search for studies written in English or Japanese reporting cases of pulmonary SH with metastasis in the lymph nodes, using the search terms 'sclerosing hemangioma', 'lung' and 'metastasis'. The results of these searches returned 17 such cases, of which 13 were in English and 4 in Japanese. Of the 4 studies written in Japanese, 3 cases were abstracts of congresses. [Table I](#tI-ol-07-04-0997){ref-type="table"} lists these cases, including the present report.

Analysis of the data provided in these reports revealed the following about SH with lymph node metastasis: i) The age of the patients ranged between 22 and 67 years \[mean ± SD, 36±15 years\]; ii) males accounted for 8/17 cases (47.1%) and females 9/17 cases (52.9%); iii) 9/17 (52.9%) primary tumors were found in the left lung and 8/17 (47.1%) were found in the right lung; iv) the left upper lobe was involved in 1/17 cases (5.9%), the left lower lobe in 8 (47.1%), the right upper lobe in 2 (11.8%), the right middle lobe in 1 (5.9%) and the right lower lobe in 5 (29.4%); and v) the primary tumors ranged in size between 10 and 100 mm (mean, 44.8±29.1 mm).

Previously, Devouassoux-Shisheboran *et al* analyzed 100 cases of SH, including one with lymph node metastasis ([@b8-ol-07-04-0997]). In this study, the clinical and pathological features of these tumors were analyzed in detail. Patients ranged in age between 13 and 76 years (mean, 46 years). There were 83 female and 17 male patients; thus, the female-to-male ratio was 5:1. The left lung was the site of 46% of tumors (17% in the left upper lobe, 25% in the left lower lobe, 1% in the fissure between the upper and lower lobe and the specific site was unknown in 3% of cases), and 54% were found in the right lung (9% in the right upper lobe, 17% in the right middle lobe, 22% in the right lower lobe, 4% in the fissure between the middle and upper lobe, 1% in the fissure between the middle and lower lobe and the specific site was unknown in 1% of cases). The tumors ranged in size between 3 and 70 mm (mean, 26 mm).

In the present study, the cases of SH with lymph node metastases that we compiled were compared with the cases of SH that Devouassoux-Shisheboran *et al* analyzed ([@b8-ol-07-04-0997]). As shown in [Table II](#tII-ol-07-04-0997){ref-type="table"}, SH with lymph node metastasis tended to occur more often in relatively young male patients than SH without metastasis. The mean size of primary SHs that had lymph node metastasis was larger than the mean size of non-metastatic primary SHs.

The findings that SHs with lymph node metastasis are larger and occur in younger patients may possibly correlate with the more rapid growth of these tumors. However, it is difficult to explain why there is a high frequency of SHs with lymph node metastasis in male patients and in the left lower lobe. Further investigation is required to elucidate the mechanism of metastasis of SH.

![Computed tomography scan images of. (A) whole chest and (B) enlarged scan of the tumor.](OL-07-04-0997-g00){#f1-ol-07-04-0997}

![Macroscopic and microscopic findings. (A) Photograph of the tumor; (B) photograph of the tumor stained with hematoxylin and eosin captured through a magnifying glass; and (C--E) various microscopic features of the tumor (magnification, ×20).](OL-07-04-0997-g01){#f2-ol-07-04-0997}

![Immunohistological staining with (A) hematoxylin and eosin, (B) anti-napsin A antibody, (C) anti-cytokeratin AE1/AE3 antibody and (D) anti-thyroid transcription factor 1 antibody (magnification, ×20).](OL-07-04-0997-g02){#f3-ol-07-04-0997}

![Lymph node metastasis of sclerosing hemangioma. (A) Photograph showing a mediastinal lymph node from the patient. Microscopic evaluation of the metastatic area with (B) hematoxylin and eosin staining and (C) staining with anti-thyroid transcription factor 1 antibody.](OL-07-04-0997-g03){#f4-ol-07-04-0997}

###### 

Cases of pulmonary sclerosing hemangioma with lymph node metastasis.

                 Primary tumor       Metastases                                                          
  ---- ---- ---- ------------------- ------------ ---------- ----- ------------------------------------- ----------------------
  1    22   M    R lower             50           1          3     Hilum                                 [@b6-ol-07-04-0997]
  2    48   M    R lower             80           2          2     Hilum                                 [@b7-ol-07-04-0997]
  3    ND   ND   ND                  35           2          ND    Hilum                                 [@b8-ol-07-04-0997]
  4    67   F    R lower             90           5          ND    Hilum, mediastinum                    [@b9-ol-07-04-0997]
  5    10   F    R middle            47           1          5     Regional                              [@b10-ol-07-04-0997]
  6    45   F    R upper             25           3          7     Hilum                                 [@b10-ol-07-04-0997]
  7    45   M    L lower             37           1          3     Mediastinum                           [@b10-ol-07-04-0997]
  8    50   F    L lower             15           1          12    Intralobular                          [@b10-ol-07-04-0997]
  9    19   M    L upper (lingula)   30           ND         ND    Intrapulmonary, intralobular          [@b11-ol-07-04-0997]
  10   19   F    L Lower             100          11         ND    Intrapulmonary, interlobular, hilum   [@b12-ol-07-04-0997]
  11   37   F    L lower             20           1          ND    Saltcellar                            [@b13-ol-07-04-0997]
  12   35   M    L lower             ND           1          ND    Mediastinum                           [@b14-ol-07-04-0997]
  13   23   M    R upper             90           Multiple   ND    Hilum                                 [@b15-ol-07-04-0997]
  14   24   F    R lower             ND           ND         ND    ND                                    [@b16-ol-07-04-0997]
  15   35   M    L lower             33           2          ND    Mediastinum                           [@b17-ol-07-04-0997]
  16   55   M    R lower             22           1          ND    Intrapulmonary                        [@b18-ol-07-04-0997]
  17   38   F    L lower             33           1          ND    Intralobular                          [@b19-ol-07-04-0997]
  18   40   F    L lower             10           1          0.5   Mediastinum                           PC

F, female; M, male; L, left; R, right; ND, not described; PC, present case.

###### 

SH cases and SH cases with lymph node metastasis.

  Parameter                       SH[a](#tfn2-ol-07-04-0997){ref-type="table-fn"}   SH with lymph node metastasis[b](#tfn3-ol-07-04-0997){ref-type="table-fn"}
  ------------------------------- ------------------------------------------------- ----------------------------------------------------------------------------
  Patients, n                     100                                               18
  Age, years (mean)               13--76 (46)                                       22--67 (36±15)
  Gender, male : female           1:5                                               8:9
  Primary tumor size, mm (mean)   3--70 (26)                                        10--100 (44.8±29.1)
  Primary tumor location, %                                                         
   Left lung                      46                                                53
   Right lung                     54                                                47
   Left upper lobe                16                                                6
   Left lower lobe                25                                                48
   Right upper lobe               9                                                 11
   Right middle lobe              16                                                6
   Right lower lobe               22                                                29

SH cases analyzed by Devouassoux-Shisheboran *et al* ([@b2-ol-07-04-0997]);

SH cases with lymph node metastasis analyzed in the present study.

SH, sclerosing hemangioma.
